EV/EBITDA
-2.31
+0.04+1.70%
7 min ago
Summary
- As of February 7, 2025, TNGX EV/EBITDA is -2.31, with a rise of +0.04 (+1.70%) during the most recent trading day.
- Over the past year, TNGX EV/EBITDA has increased by +9.08 (+79.72%).
- TNGX EV/EBITDA is now -19.69% below its all-time high of -1.93.
Performance
TNGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TNGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.7% | -2.0% | -1.9% |
| 1 m1 month | +13.2% | -13.3% | -12.7% |
| 3 m3 months | +0.4% | -0.7% | -0.6% |
| 6 m6 months | +67.4% | -65.6% | -64.6% |
| ytdytd | +1.7% | -1.7% | -1.6% |
| 1 y1 year | +79.7% | -75.1% | -75.7% |
| 5 y5 years | - | - | - |
TNGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -17.3% | -2.66 | +13.2% | |
| 3 m | 3-month | -1.97 | -17.3% | -3.09 | +25.2% |
| 6 m | 6-month | -1.97 | -17.3% | -9.62 | +76.0% |
| 1 y | 1-year | -1.97 | -17.3% | -11.47 | +79.9% |
| 3 y | 3-year | -1.93 | -19.7% | -12.04 | +80.8% |
| 5 y | 5-year | -1.93 | -19.7% | -23.77 | +90.3% |
| alltime | all time | -1.93 | -19.7% | -23.77 | +90.3% |
Tango Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.31(-1.7%) |
| 2024 | -2.35(-73.3%) |
| Date | Value |
|---|---|
| 2023 | -8.81(+55.4%) |
| 2022 | -5.67(-60.2%) |
| 2021 | -14.26 |
FAQ
- What is Tango Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Tango Therapeutics?
- What is TNGX EV/EBITDA year-to-date change?
- What is Tango Therapeutics EV/EBITDA year-on-year change?
What is Tango Therapeutics EV/EBITDA?
The current EV/EBITDA of TNGX is -2.31
What is the all time high EV/EBITDA for Tango Therapeutics?
Tango Therapeutics all-time high EV/EBITDA is -1.93
What is TNGX EV/EBITDA year-to-date change?
Tango Therapeutics EV/EBITDA has changed by +0.04 (+1.70%) since the beginning of the year
What is Tango Therapeutics EV/EBITDA year-on-year change?
Over the past year, TNGX EV/EBITDA has changed by +9.08 (+79.72%)